Cargando…
Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked recessive genetic disease in which the dystrophin coding for a membrane stabilizing protein is mutated. Recently, the vasculature has also shown to be perturbed in DMD and DMD model mdx mice. Recent DMD transcriptomics revealed the defects were correl...
Autores principales: | Verma, Mayank, Shimizu-Motohashi, Yuko, Asakura, Yoko, Ennen, James P., Bosco, Jennifer, Zhou, Zhiwei, Fong, Guo-Hua, Josiah, Serene, Keefe, Dennis, Asakura, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932757/ https://www.ncbi.nlm.nih.gov/pubmed/31877123 http://dx.doi.org/10.1371/journal.pgen.1008468 |
Ejemplares similares
-
Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013) -
VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy
por: Bosco, Jennifer, et al.
Publicado: (2021) -
Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2014) -
Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022) -
Vascular therapy for Duchenne muscular dystrophy (DMD)
por: Thapa, Sangharsha, et al.
Publicado: (2023)